HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yating Xu Selected Research

Yating Xu Research Topics

Disease

3Neoplasms (Cancer)
01/2021 - 10/2014
2Stomach Neoplasms (Stomach Cancer)
01/2021 - 10/2014
1Coinfection
05/2022
1Epstein-Barr Virus Infections
05/2022
1Infections
05/2022
1Hemorrhagic Stroke
01/2022
1Cerebral Hemorrhage
01/2022
1Glioma (Gliomas)
01/2021
1Hepatocellular Carcinoma (Hepatoma)
01/2021
1Lung Neoplasms (Lung Cancer)
01/2021
1Osteosarcoma (Osteogenic Sarcoma)
01/2021
1Colorectal Neoplasms (Colorectal Cancer)
01/2021
1Pre-Eclampsia (Preeclampsia)
01/2017
1Gout
05/2016
1Neoplasm Metastasis (Metastasis)
10/2014

Drug/Important Bio-Agent (IBA)

2PolymersIBA
01/2022 - 05/2016
2Long Noncoding RNAIBA
01/2021 - 01/2021
2Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2021
1HydrogelsIBA
01/2022
1Peptides (Polypeptides)IBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1LipidsIBA
01/2022
1Biological ProductsIBA
01/2021
1N-methyladenosineIBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
16-methyladenineIBA
01/2021
15-Methylcytosine (5 Methylcytosine)IBA
01/2021
15-hydroxymethylcytosineIBA
01/2017
1CationsIBA
05/2016
1PurinesIBA
05/2016
1purineIBA
05/2016
1FlavonoidsIBA
10/2014
1baicaleinIBA
10/2014
1VimentinIBA
10/2014
1Transforming Growth Factors (Transforming Growth Factor)IBA
10/2014
1Cadherins (E-Cadherin)IBA
10/2014

Therapy/Procedure

3Therapeutics
01/2022 - 01/2021
1Drug Therapy (Chemotherapy)
05/2022